{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:28:11Z","timestamp":1786652891498,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Niger J Clin Pract"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/1119-3077.154208","type":"journal-article","created":{"date-parts":[[2015,3,30]],"date-time":"2015-03-30T08:33:56Z","timestamp":1427704436000},"page":"626","source":"Crossref","is-referenced-by-count":3,"title":["Lipoatrophy among patients on antiretroviral therapy in Lagos, Nigeria: Prevalence, pattern and association with cardiovascular risk factors"],"prefix":"10.4103","volume":"18","author":[{"given":"SO","family":"Iwuala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OA","family":"Lesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MA","family":"Olamoyegun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AA","family":"Sabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OA","family":"Fasanmade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1119-3077.154208-1","first-page":"F51","volume-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"key-10.4103\/1119-3077.154208-2","first-page":"F25","volume-title":"A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: Contribution to protease inhibitor-related lipodystrophy syndrome","author":"Carr","year":"2000","journal-title":"AIDS"},{"key":"key-10.4103\/1119-3077.154208-3","first-page":"1659","volume-title":"A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy","author":"Saint-Marc","year":"1999","journal-title":"AIDS"},{"key":"key-10.4103\/1119-3077.154208-4","first-page":"180","volume-title":"Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular disease in human immunodeficiency virus infection","author":"Tanwani","year":"2003","journal-title":"South Med J"},{"key":"key-10.4103\/1119-3077.154208-5","unstructured":"World Health Organization (WHO). Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public heath approach. Available from: http:\/\/www.who.int\/hiv\/pub\/guidelines\/artadultguidelines.pdf. [Last accessed on 2014 Oct 13]."},{"key":"key-10.4103\/1119-3077.154208-6","first-page":"S140","volume-title":"Relationship between HAART adherence and adipose tissue alterations","author":"Ammassari","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.4103\/1119-3077.154208-7","first-page":"137","volume-title":"A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals","author":"Power","year":"2003","journal-title":"Sex Transm Infect"},{"key":"key-10.4103\/1119-3077.154208-8","first-page":"369","volume-title":"Relationship between lipoatrophy and quality of life","author":"Echavez","year":"2005","journal-title":"AIDS Read"},{"key":"key-10.4103\/1119-3077.154208-9","first-page":"1993","volume-title":"Combination antiretroviral therapy and the risk of myocardial infarction","author":"Friis-M\u00f8ller","year":"2003","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1119-3077.154208-10","first-page":"702","volume-title":"Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection","author":"Bozzette","year":"2003","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1119-3077.154208-11","first-page":"1837","volume-title":"Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women","author":"Jacobson","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/1119-3077.154208-12","first-page":"293","volume-title":"HIV lipodystrophy: Prevalence, severity and correlates of risk in Australia","author":"Miller","year":"2003","journal-title":"HIV Med"},{"key":"key-10.4103\/1119-3077.154208-13","first-page":"224","volume-title":"Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4-to 9-year antiretroviral therapy in Senegal: A case-control study","author":"Mercier","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.4103\/1119-3077.154208-14","first-page":"38","volume-title":"Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population","author":"Hansen","year":"2006","journal-title":"HIV Med"},{"key":"key-10.4103\/1119-3077.154208-15","unstructured":"United Nations Programme on HIV\/AIDS (UNAIDS). Access to antiretroviral therapy in Africa. Status report on progress towards the 2015 targets. Available from: http:\/\/www.unaids.org\/sites\/default\/files\/en\/media\/unaids\/contentassets\/documents\/unaidspublication\/2013\/20130630_treatment_report_en.pdf. [Last accessed on 2014 Oct 14]."},{"key":"key-10.4103\/1119-3077.154208-16","first-page":"793","volume-title":"High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda","author":"Van","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.4103\/1119-3077.154208-17","first-page":"1389","volume-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population","author":"Lichtenstein","year":"2001","journal-title":"AIDS"},{"key":"key-10.4103\/1119-3077.154208-18","first-page":"605","volume-title":"Prevalence of lipodystrophy in Thai-HIV infected patients","author":"Puttawong","year":"2004","journal-title":"J Med Assoc Thai"},{"key":"key-10.4103\/1119-3077.154208-19","first-page":"199","volume-title":"Lipodystrophy and dyslipidemia among patients taking first-line, World Health Organization-recommended highly active antiretroviral therapy regimens in Western India","author":"Pujari","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.4103\/1119-3077.154208-20","unstructured":"World Health Organization (WHO). Definition, diagnosis and classification of diabetes mellitus: Report of a WHO consultation. Geneva, Switzerland: WHO Publication WHO\/NCD\/NCS\/99-92; 1999."},{"key":"key-10.4103\/1119-3077.154208-21","first-page":"2486","volume-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","author":"Expert","year":"2001","journal-title":"JAMA"},{"key":"key-10.4103\/1119-3077.154208-22","first-page":"2560","volume-title":"The Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"key-10.4103\/1119-3077.154208-23","first-page":"1S","volume-title":"Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome.Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases","author":"Centers","year":"1987","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.4103\/1119-3077.154208-24","first-page":"371","volume-title":"Incidence of lipodystrophy and metabolic disorders in patients starting non-nucleoside reverse transcriptase inhibitors in Benin","author":"Zannou","year":"2009","journal-title":"Antivir Ther"},{"key":"key-10.4103\/1119-3077.154208-25","first-page":"43","volume-title":"Prevalence of lipodystrophy and metabolic syndrome among HIV positive individuals on Highly Active Anti-Retroviral treatment in Jimma, South West Ethiopia","author":"Berhane","year":"2012","journal-title":"Pan Afr Med J"},{"key":"key-10.4103\/1119-3077.154208-26","first-page":"239","volume-title":"Clinical lipoatrophy in HIV-1 patients on HAART is not associated with increased abdominal girth, hyperlipidaemia or glucose intolerance","author":"Worm","year":"2002","journal-title":"HIV Med"},{"key":"key-10.4103\/1119-3077.154208-27","first-page":"121","volume-title":"Fat distribution in men with HIV infection","author":"Bacchetti","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.4103\/1119-3077.154208-28","first-page":"726","volume-title":"An objective case definition of lipodystrophy in HIV-infected adults: A case-control study","author":"Carr","year":"2003","journal-title":"Lancet"},{"key":"key-10.4103\/1119-3077.154208-29","first-page":"184","volume-title":"Characteristics and factors associated with the clinical forms of lipoatrophy during highly active antiretroviral therapy in Ouagadougou, Burkina Faso","author":"Guira","year":"2014","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"key-10.4103\/1119-3077.154208-30","first-page":"1309","volume-title":"Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection","author":"Mallal","year":"2000","journal-title":"AIDS"},{"key":"key-10.4103\/1119-3077.154208-31","first-page":"263","volume-title":"Increased adipocyte apoptosis in lipoatrophy improves within 48 weeks of switching patient therapy from Stavudine to abacavir or zidovudine","author":"Cherry","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.4103\/1119-3077.154208-32","first-page":"1329","volume-title":"Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy","author":"Nolan","year":"2003","journal-title":"AIDS"},{"key":"key-10.4103\/1119-3077.154208-33","first-page":"145","volume-title":"Prevalence of and clinical factors associated with lipoatrophy in HIV-infected Koreans receiving highly active antiretroviral therapy","author":"Han","year":"2009","journal-title":"Tohoku J Exp Med"},{"key":"key-10.4103\/1119-3077.154208-34","first-page":"142","volume-title":"Lipodystrophy and weight changes: Data from the Swiss HIV Cohort Study, 2000-2006","author":"Nguyen","year":"2008","journal-title":"HIV Med"},{"key":"key-10.4103\/1119-3077.154208-35","first-page":"139","volume-title":"Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized study","author":"Podzamczer","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.4103\/1119-3077.154208-36","first-page":"508","volume-title":"Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides.Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384","author":"Dub\u00e9","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.4103\/1119-3077.154208-37","first-page":"337","volume-title":"Stavudine but not didanosine as part of HAART contributes to peripheral lipoatrophy: A substudy from the Antiretroviral Regimen Evaluation Study (ARES)","author":"Lowe","year":"2007","journal-title":"HIV Clin Trials"},{"key":"key-10.4103\/1119-3077.154208-38","first-page":"590","volume-title":"Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial","author":"Mulligan","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.4103\/1119-3077.154208-39","first-page":"795","volume-title":"Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin","author":"Nagy","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/1119-3077.154208-40","first-page":"44","volume-title":"The associations of regional adipose tissue with lipid and lipoprotein levels in HIV-infected men","author":"Wohl","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.4103\/1119-3077.154208-41","first-page":"2001","volume-title":"Elevated blood pressure in subjects with lipodystrophy","author":"Sattler","year":"2001","journal-title":"AIDS"},{"key":"key-10.4103\/1119-3077.154208-42","first-page":"811","volume-title":"Predictors of hypertension and changes of blood pressure in HIV-infected patients","author":"Thi\u00e9baut","year":"2005","journal-title":"Antivir Ther"},{"key":"key-10.4103\/1119-3077.154208-43","first-page":"1377","volume-title":"Hypertension among HIV patients: Prevalence and relationships to insulin resistance and metabolic syndrome","author":"Gazzaruso","year":"2003","journal-title":"J Hypertens"},{"key":"key-10.4103\/1119-3077.154208-44","first-page":"496","volume-title":"Lipoatrophy and lipohypertrophy are independently associated with hypertension","author":"Crane","year":"2009","journal-title":"HIV Med"},{"key":"key-10.4103\/1119-3077.154208-45","first-page":"593","volume-title":"Central\/Peripheral fat mass ratio is associated with increased risk of hypertension in HIV-infected patients","author":"Freitas","year":"2012","journal-title":"J Clin Hypertens (Greenwich)"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:27:46Z","timestamp":1786649266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1119-3077.154208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"alternative-id":["154208"],"URL":"https:\/\/doi.org\/10.4103\/1119-3077.154208","relation":{},"ISSN":["1119-3077"],"issn-type":[{"value":"1119-3077","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}